Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$584K Sell
2,775
-169
-6% -$36.2K 0.02% 582
2026
Q1
$651K Sell
2,944
-379
-11% -$92.7K 0.03% 477
2025
Q4
$842K Buy
3,323
+380
+13% +$95.4K 0.04% 378
2025
Q3
$728K Buy
2,943
+517
+21% +$124K 0.04% 389
2025
Q2
$583K Buy
2,426
+616
+34% +$143K 0.04% 429
2025
Q1
$410K Buy
1,810
+666
+58% +$146K 0.03% 491
2024
Q4
$235K Sell
1,144
-181
-14% -$39.7K 0.02% 625
2024
Q3
$321K Buy
1,325
+317
+31% +$74.1K 0.03% 444
2024
Q2
$221K Buy
1,008
+307
+44% +$66.7K 0.03% 469
2024
Q1
$158K Buy
701
+199
+40% +$44.9K 0.03% 471
2023
Q4
$110K Buy
+502
New +$106K 0.03% 505

Other funds holding STE

GAMMA Investing's STE Position: Q2 2026 in Review

GAMMA Investing reduced its Steris (STE) stake by 5.7% in Q2 2026, selling an estimated $36.2K and leaving 2,775 shares worth $584K. The position accounts for 0.02% of the portfolio, ranked #582.

GAMMA Investing first reported a position in STE in Q4 2023 and has held it in 11 quarters since. The position peaked at $842K in Q4 2025. 108 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • GAMMA Investing held 2,775 shares of Steris worth $584K as of Q2 2026.
  • GAMMA Investing sold 169 Steris shares in Q2 2026, an estimated $36.2K.
  • Steris made up 0.02% of GAMMA Investing's portfolio in Q2 2026, its #582 holding.
  • GAMMA Investing first reported a position in Steris in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Steris position peaked at $842K in Q4 2025.
  • 108 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.